EP1232179A4 - 15 human secreted proteins - Google Patents

15 human secreted proteins

Info

Publication number
EP1232179A4
EP1232179A4 EP00979145A EP00979145A EP1232179A4 EP 1232179 A4 EP1232179 A4 EP 1232179A4 EP 00979145 A EP00979145 A EP 00979145A EP 00979145 A EP00979145 A EP 00979145A EP 1232179 A4 EP1232179 A4 EP 1232179A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00979145A
Other languages
German (de)
French (fr)
Other versions
EP1232179A1 (en
Inventor
Steven M Ruben
George A Komatsoulis
Henrik S Olsen
Roxanne D Duan
Reinhard Ebner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to EP04007416A priority Critical patent/EP1475389A1/en
Publication of EP1232179A1 publication Critical patent/EP1232179A1/en
Publication of EP1232179A4 publication Critical patent/EP1232179A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP00979145A 1999-11-12 2000-11-08 15 human secreted proteins Withdrawn EP1232179A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04007416A EP1475389A1 (en) 1999-11-12 2000-11-08 Human secreted protein that shares sequence homology with the murine Sperizin protein

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16483499P 1999-11-12 1999-11-12
US164834P 1999-11-12
US22400700P 2000-08-04 2000-08-04
US224007P 2000-08-04
PCT/US2000/030679 WO2001034644A1 (en) 1999-11-12 2000-11-08 15 human secreted proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04007416A Division EP1475389A1 (en) 1999-11-12 2000-11-08 Human secreted protein that shares sequence homology with the murine Sperizin protein

Publications (2)

Publication Number Publication Date
EP1232179A1 EP1232179A1 (en) 2002-08-21
EP1232179A4 true EP1232179A4 (en) 2003-06-04

Family

ID=26860896

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00979145A Withdrawn EP1232179A4 (en) 1999-11-12 2000-11-08 15 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1232179A4 (en)
JP (1) JP2003513658A (en)
AU (1) AU1655701A (en)
CA (1) CA2388914A1 (en)
WO (1) WO2001034644A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046394A1 (en) * 2000-12-07 2002-06-13 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
AU2002327176A1 (en) * 2001-06-06 2002-12-16 Human Genome Sciences, Inc. 20 human secreted proteins
US20040234537A1 (en) * 2001-07-06 2004-11-25 Lydie Bougueleret Carcinoma-related peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1045904B1 (en) * 1998-01-15 2007-04-25 Whitehead Institute For Biomedical Research Fatty acid transport proteins
DK1490386T3 (en) * 1998-03-10 2008-12-15 Genentech Inc New polypeptide and nucleic acids encoding this

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 23 January 1997 (1997-01-23), HILLIER ET AL.: "zr40b06.r1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:665843 5' similar to TR:G563829 G563829 FATTY ACID TRANSPORT PROTEIN. ;, mRNA sequence.", XP002225523, Database accession no. AA193416 *
DATABASE EMBL [online] EBI; 27 May 1999 (1999-05-27), NCI-CGAP: "tu72b01.x1 NCI_CGAP_Gas4 Homo sapiens cDNA clone IMAGE:2256553 3' similar to TR:O88561 O88561 FATTY ACID TRANSPORT PROTEIN 3 ;, mRNA sequence.", XP002225524, Database accession no. AI679161 *
HIRSCH DAVID ET AL: "A family of fatty acid transporters conserved from mycobacterium to man.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 95, no. 15, 21 July 1998 (1998-07-21), July 21, 1998, pages 8625 - 8629, XP002225522, ISSN: 0027-8424 *
JACOBS K A ET AL: "A GENETIC SELECTION FOR ISOLATING CDNAS ENCODING SECRETED PROTEINS", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, 1 October 1997 (1997-10-01), pages 289 - 296, XP002045919, ISSN: 0378-1119 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1996, pages 7108 - 7113, XP002911164, ISSN: 0027-8424 *
SCHAFFER JEAN E ET AL: "Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein.", CELL, vol. 79, no. 3, 1994, pages 427 - 436, XP002081438, ISSN: 0092-8674 *
See also references of WO0134644A1 *

Also Published As

Publication number Publication date
WO2001034644A1 (en) 2001-05-17
CA2388914A1 (en) 2001-05-17
AU1655701A (en) 2001-06-06
JP2003513658A (en) 2003-04-15
EP1232179A1 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
EP1218408A4 (en) 32 human secreted proteins
EP1212343A4 (en) 52 human secreted proteins
EP1181390A4 (en) 27 human secreted proteins
EP1224285A4 (en) 27 human secreted proteins
EP1212342A4 (en) 18 human secreted proteins
EP1226231A4 (en) 19 human secreted proteins
EP1175438A4 (en) 62 human secreted proteins
EP1192278A4 (en) 48 human secreted proteins
EP1192176A4 (en) 49 human secreted proteins
EP1165827A4 (en) 45 human secreted proteins
EP1175439A4 (en) 49 human secreted proteins
EP1159284A4 (en) 33 human secreted proteins
EP1189917A4 (en) 48 human secreted proteins
EP1185543A4 (en) 50 human secreted proteins
EP1224201A4 (en) 32 human secreted proteins
EP1173477A4 (en) 49 human secreted proteins
EP1203005A4 (en) 25 human secreted proteins
EP1206573A4 (en) 26 human secreted proteins
EP1144614A4 (en) 33 human secreted proteins
EP1165602A4 (en) 49 human secreted proteins
EP1171460A4 (en) 48 human secreted proteins
EP1169332A4 (en) 49 human secreted proteins
EP1165828A4 (en) 50 human secreted proteins
EP1185285A4 (en) 49 human secreted proteins
EP1171626A4 (en) 50 human secreted proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020607

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030416

17Q First examination report despatched

Effective date: 20030919

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040330